SIOP protocol

chemotherapy protocol consisting of dactinomycin & vincristine; used in treatment of Wilms' tumor

Also Known As:

EE-4A regimen; SIOP-93-01 protocol

Therapeutics: 1158551
- Drug Therapy: 293145
  - Combination Drug Therapy: 12066
    - Antineoplastic Combined Chemotherapy Protocols: 35
      - SIOP protocol: 16
  - Antineoplastic Protocols: 55
    - Antineoplastic Combined Chemotherapy Protocols: 35
      - SIOP protocol: 16
- Clinical Protocols
  - Antineoplastic Protocols: 55
    - Antineoplastic Combined Chemotherapy Protocols: 35
      - SIOP protocol: 16
Heterocyclic Compounds: 198
- Alkaloids: 5398
  - Indole Alkaloids: 200
    - Secologanin Tryptamine Alkaloids: 81
      - Vinca Alkaloids: 463
        Vincristine: 9251
        SIOP protocol: 16
- Fused-Ring Heterocyclic Compounds
  - 2-Ring Heterocyclic Compounds
    - Indoles: 200
      - Indole Alkaloids: 200
        Secologanin Tryptamine Alkaloids: 81
        Vinca Alkaloids: 463
        Vincristine: 9251
        SIOP protocol: 16
    - Indolizines: 3
      - Indolizidines: 2
        Indole Alkaloids: 200
        Secologanin Tryptamine Alkaloids: 81
        Vinca Alkaloids: 463
        Vincristine: 9251
        SIOP protocol: 16
  - 3-Ring Heterocyclic Compounds
    - Dactinomycin: 2073
      - SIOP protocol: 16
Polycyclic Compounds: 6
- Macrocyclic Compounds: 15
  - Cyclic Peptides: 530
    - Dactinomycin: 2073
      - SIOP protocol: 16
Amino Acids, Peptides, and Proteins: 1
- Peptides: 82426
  - Cyclic Peptides: 530
    - Dactinomycin: 2073
      - SIOP protocol: 16

de la SFCE GO-AJA au nom de l’ANOCEF Selected Research

de la SFCE GO-AJA au nom de l’ANOCEF Research Topics